Literature DB >> 15515971

Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families.

Lilian Jara1, Sandra Ampuero, Eudocia Santibáñez, Lorena Seccia, Juan Rodríguez, Mario Bustamante Guillermo Lay-Son, José Manuel Ojeda, José Miguel Reyes, Rafael Blanco.   

Abstract

BRCA1 gene mutations account for nearly all families with multiple cases of both early onset breast and/or ovarian cancer and about 30% of hereditary breast cancer. Although to date more than 1,237 distinct mutations, polymorphisms, and variants have been described, several mutations have been found to be recurrent in this gene. We have analyzed 63 Chilean breast/ovarian cancer families for eighteen frequent BRCA1 mutations. The analysis of the five exons and two introns in which these mutations are located was made using mismatch PCR assay, ASO hybridization assay, restriction fragment analysis, allele specific PCR assay and direct sequentiation techniques. Two BRCA1 mutations (185delAG and C61G) and one variant of unknown significance (E1250K) were found in four of these families. Also, a new mutation (4185delCAAG) and one previously described polymorphism (E1038G) were found in two other families. The 185delAG was found in a 3.17% of the families and the others were present only in one of the families of this cohort. Therefore these mutations are not prominent in the Chilean population. The variant of unknown significance and the polymorphism detected could represent a founder effect of Spanish origin.

Entities:  

Mesh:

Year:  2004        PMID: 15515971     DOI: 10.4067/s0716-97602004000300011

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  5 in total

1.  Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

Authors:  Cynthia Villarreal-Garza; Rosa María Alvarez-Gómez; Carlos Pérez-Plasencia; Luis A Herrera; Josef Herzog; Danielle Castillo; Alejandro Mohar; Clementina Castro; Lenny N Gallardo; Dolores Gallardo; Miguel Santibáñez; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Cancer       Date:  2014-09-18       Impact factor: 6.860

2.  Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

Authors:  Julie Dutil; Jose L Colon-Colon; Jaime L Matta; Rebecca Sutphen; Miguel Echenique
Journal:  Cancer Genet       Date:  2012-05

3.  The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.

Authors:  C Villarreal-Garza; J N Weitzel; M Llacuachaqui; E Sifuentes; M C Magallanes-Hoyos; L Gallardo; R M Alvarez-Gómez; J Herzog; D Castillo; R Royer; Mohammad Akbari; F Lara-Medina; L A Herrera; A Mohar; S A Narod
Journal:  Breast Cancer Res Treat       Date:  2015-02-26       Impact factor: 4.872

4.  Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.

Authors:  Patricia Ashton-Prolla; Fernando Regla Vargas
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

Review 5.  Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.

Authors:  Laura Keren Urbina-Jara; Augusto Rojas-Martinez; Emmanuel Martinez-Ledesma; Dione Aguilar; Cynthia Villarreal-Garza; Rocio Ortiz-Lopez
Journal:  Genes (Basel)       Date:  2019-10-10       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.